Page 151 - MI-2-3
P. 151
Microbes & Immunity Characterizing low-grade CNS tumors
13. Zheng Y, Graeber MB. Microglia and brain macrophages Rural Pract. 2016;7(4):510-514.
as drivers of glioma progression. Int J Mol Sci. doi: 10.4103/0976-3147.188626
2022;23(24):15612.
24. Akyurek S, Chang EL, Yu TK, et al. Spinal myxopapillary
doi: 10.3390/ijms232415612
ependymoma outcomes in patients treated with surgery and
14. Vidyarthi A, Agnihotri T, Khan N, et al. Predominance of radiotherapy at M.D. Anderson cancer center. J Neurooncol.
M2 macrophages in gliomas leads to the suppression of 2006;80(2):177-183.
local and systemic immunity. Cancer Immunol Immunother. doi: 10.1007/s11060-006-9169-2.
2019;68(12):1995-2004.
25. Snuderl M, Chi SN, De Santis SM, et al. Prognostic value
doi: 10.1007/s00262-019-02423-8
of tumor microinvasion and metalloproteinases expression
15. Rajendran G, Shanmuganandam K, Bendre A, in intracranial pediatric ependymomas. J Neuropathol Exp
Muzumdar D, Goel A, Shiras A. Epigenetic regulation Neurol. 2008;67(9):911-920.
of DNA methyltransferases: DNMT1 and DNMT3B in doi: 10.1097/NEN.0b013e318184f413
gliomas. J Neurooncol. 2011;104(2):483-494.
26. Chen X, Li C, Che X, Chen H, Liu Z. Spinal
doi: 10.1007/s11060-010-0520-2
myxopapillary ependymomas: A retrospective clinical
16. Zhao Y, Gan L, Ren L, Lin Y, Ma C, Lin X. Factors and immunohistochemical study. Acta Neurochir (Wien).
influencing the blood-brain barrier permeability. Brain Res. 2016;158(1):101-107.
2022;1788:147937.
doi: 10.1007/s00701-015-2637-8
doi: 10.1016/j.brainres.2022.147937
27. Ghosh K, Ghosh S, Chatterjee U, Chaudhuri S, Anirban A.
17. Alanen KA, Joensuu H, Klemi PJ. DNA ploidy and cell- Microglial contribution to glioma progression: An
cycle analysis in pancreatic and ampullary carcinoma: Flow immunohistochemical study in Eastern India. Asian Pac J
cytometric study of formalin-fixed paraffin-embedded tissue. Cancer Prev. 2016;17(6):2767-2773.
Virchows Arch A Pathol Anat Histopathol. 1991;419(3):255-256.
28. Sato K, Kuratsu J, Takeshima H, Yoshimura T, Ushio Y.
doi: 10.1007/BF01626357 Expression of monocyte chemoattractant protein-1 in
meningioma. J Neurosurg. 1995;82(5):874-878.
18. Bready D, Placantonakis DG. Molecular pathogenesis of
low-grade glioma. Neurosurg Clin N Am. 2019;30(1):17-25. doi: 10.3171/jns.1995.82.5.0874
doi: 10.1016/j.nec.2018.08.011 29. Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure,
function, and regulation of the blood-brain barrier tight
19. Yrysov K, Arstanbekov N, Mamytov M, Akmataliev A,
Turganbaev B, Vityala Y. Postoperative complications in junction in central nervous system disorders. Front Physiol.
patients with intracranial meningiomas who underwent 2020;11:914.
surgery. Biomedicine. 2023;43(3):34-40. doi: 10.3389/fphys.2020.00914
doi: 10.51248/.v43i3.2886 30. Yan D, Kowal J, Akkari L, et al. Inhibition of colony
stimulating factor-1 receptor abrogates microenvironment-
20. Chang JH, Chang JW, Choi JY, Park YG, Chung SS.
Complications after gamma knife radiosurgery for mediated therapeutic resistance in gliomas. Oncogene.
benign meningiomas. J Neurol Neurosurg Psychiatry. 2017;36(43):6049-6058.
2003;74(2):226-230. doi: 10.1038/onc.2017.261
doi: 10.1136/jnnp.74.2.226 31. Kvisten M, Mikkelsen VE, Stensjøen AL, Solheim O, Van
Der Want J, Torp SH. Microglia and macrophages in human
21. Bertrand KC, Klimo P. Recent advancements in
ependymoma: Challenges and therapeutic opportunities. glioblastomas: A morphological and immunohistochemical
Pediatr Neurosurg. 2023;58(5):307-312. study. Mol Clin Oncol. 2019;11(1):31-36.
doi: 10.3892/mco.2019.1856
doi: 10.1159/000530868
32. Gutmann DH, Kettenmann H. Microglia/brain macrophages
22. Thotakura M, Tirumalasetti N, Krishna R. Role of Ki-67
labeling index as an adjunct to the histopathological as central drivers of brain tumor pathobiology. Neuron.
diagnosis and grading of astrocytomas. J Cancer Res Ther. 2019;104(3):442-449.
2014;10(3):641-645. doi: 10.1016/j.neuron.2019.08.028
doi: 10.4103/0973-1482.139154 33. Dubuc AM, Mack S, Unterberger A, Northcott PA,
Taylor MD. The epigenetics of brain tumors. Methods Mol
23. Shivaprasad NV, Satish S, Ravishankar S, Vimalambike MG.
Ki-67 immunostaining in astrocytomas: Association with Biol. 2012;863:139-153.
histopathological grade - a South Indian study. J Neurosci doi: 10.1007/978-1-61779-612-8_8
Volume 2 Issue 3 (2025) 143 doi: 10.36922/MI025190040

